Use of contemporary biomaterials in chronic osteomyelitis treatment: Clinical lessons learned and literature review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33098587.
- Also identified by DOI 10.1002/jor.24896 and PMC identifier 7894567.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Chronic osteomyelitis has always been a therapeutic challenge for patient and surgeon due to the specific problems related with bone infection and bacterial biofilm eradication. Other than being the cause of infection or facilitating spread or persistence of infection, biomaterials are also becoming a tool in the treatment of infection. Certain novel biomaterials have unique and ideal properties that render them perfectly suited to combat infection and are therefore used more and more in the treatment of chronic bone infections. In case of infection treatment, there is still debate whether these properties should be focused on bone regeneration and/or their antimicrobial properties. These properties will be of even greater importance with the challenge of emerging antimicrobial resistance. This review highlights indications for use and specific material properties of some commonly used contemporary biomaterials for this indication as well as clinical experience and a literature overview.
Medical subject headings
- Anti-Bacterial Agents
- Biocompatible Materials
- Osteomyelitis